A Safety and Pharmacokinetic Study Between HLX02 and Herceptin®(US-licensed and EU-approved) in Healthy Chinese Male Subjects

NCT04670796 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

111

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: HLX02
DRUG: EU-sourced Trastuzumab (Herceptin®)
DRUG: US-licensed Trastuzumab (Herceptin®)

Sponsor

Shanghai Henlius Biotech